Alphatec Holdings Inc. (ATEC)
ATEC trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1350653/000119312526067393/0001193125-26-067393-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | ATEC on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | United States |
| IPO year | 2006 |
| SEC CIK | 0001350653 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $764.2M |
| Net income | -$143.4M |
| Operating income | -$82.1M |
| Net margin | -18.8% |
| Operating margin | -10.7% |
| Revenue growth | +25.0% |
| Cash | $160.8M |
| Total assets | $791.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.4× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-10-29 |
| Cash and burn | $79.9M cash; operating cash flow $15.3M a quarter. | Report 2026-09-30 |
| Shares outstanding | 155,139,824 (2026-10-22); 148,550,185 a year earlier; 136,300,664 three years earlier. | Cover page 2026-10-22 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | Deloitte & Touche LLP, San Diego, California, United States | PCAOB Form AP 2026-03-03 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $2.0M, sold $50.2M on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $221.2M | -$5.5M | $18.9M | $79.9M | $552.3M | $839.7M | 10-Q 2026-10-29 |
| Q2 2026 2026-06-30 | $213.5M | -$25.8M | $20.5M | $118.7M | $640.8M | $815.1M | 10-Q 2026-08-04 |
| Q1 2026 2026-03-31 | $192.1M | -$33.9M | $1.3M | $139.9M | $638.9M | $787.1M | 10-Q 2026-05-05 |
| Q4 2025 2025-12-31 | $212.9M | -$21.7M | $20.7M | $160.8M | $630.5M | $764.2M | 10-K 2026-02-24 |
| Q3 2025 2025-09-30 | $196.5M | -$28.6M | $14.0M | $155.7M | $624.3M | $728.0M | 10-Q 2026-10-29 |
| Q2 2025 2025-06-30 | $185.5M | -$41.1M | $15.5M | $157.1M | $555.8M | $682.2M | 10-Q 2026-08-04 |
| Q1 2025 2025-03-31 | $169.2M | -$51.9M | -$5.0M | $153.2M | $551.0M | $642.3M | 10-Q 2026-05-05 |
| Q4 2024 2024-12-31 | $176.8M | -$33.3M | $10.5M | $138.8M | $577.8M | $611.6M | 10-K 2026-02-24 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | S-3ASR | 2024-11-15 |
| Latest annual report | 10-K | 2026-02-24 |
| Latest quarterly / interim | 10-Q | 2026-10-29 |
| Latest current report | 8-K | 2026-10-29 |
| Latest proxy | DEFA14A | 2026-04-29 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -5.0% |
| 1 month | -34.7% |
| 3 months | -27.5% |
| Year to date | -66.4% |
| 1 year | -65.0% |
| From 52-week high | -68.8% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| SIBN | SI-BONE Inc. | $23.41 | -0.13% | $1.1B |
| SGP | SpyGlass Pharma Inc. | $32.24 | -1.95% | $1.1B |
| IRMD | iRadimed Corporation | $84.84 | -0.60% | $1.1B |
| IART | Integra LifeSciences Holdings Corporation | $13.98 | -2.92% | $1.1B |
| DRTS | Alpha Tau Medical Ltd. | $11.97 | -10.54% | $1.1B |
| AORT | Artivion Inc. | $18.47 | -3.30% | $901.1M |
| BVS | Bioventus Inc. | $10.46 | -1.88% | $881.4M |
| TNDM | Tandem Diabetes Care Inc. | $18.48 | -7.92% | $1.3B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier